Related Experiment Videos
Oral immunization of monkeys with polyvalent dysentery vaccine
Abstract:
Macaca mulatta monkeys were immunized orally with polyvalent Boivin extract of Shigella flexneri 2a, 3a, 4a, 4b, 6 and Shigella sonnei. The total immumizing dose for each component was equivalent to 1.2 X 10(12) cells. After challenge with 7.5 X 10(10) cells of a virulent S. flexneri 2a strain, out of 20 immunized animals 2 developed dysentery and 4 showed mild dyspepsia; all 6 control animals became ill with dysentery. Vaccination failed to influence the incidence, duration or the intermittent character of shigella excretion. Protective antibodies appeared in high titre in the serum of immunized animals.
Insights
Oral vaccination with Shigella extract in rhesus monkeys induced protective antibodies but did not prevent Shigella infection or excretion. This study highlights the complexity of developing effective Shigella vaccines.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Shigella infections cause significant diarrheal disease globally.
- Developing effective vaccines against Shigella remains a challenge.
- Oral vaccination strategies are being explored for enteric pathogens.
Purpose of the Study:
- To evaluate the efficacy of an oral polyvalent Shigella vaccine in a non-human primate model.
- To assess the vaccine's ability to confer protection against virulent Shigella challenge.
- To investigate the impact of vaccination on Shigella excretion patterns.
Main Methods:
- Macaca mulatta monkeys were orally immunized with a polyvalent Boivin extract of Shigella flexneri and Shigella sonnei.
- Animals were subsequently challenged with a virulent Shigella flexneri 2a strain.
- Clinical signs, Shigella excretion, and serum antibody titers were monitored.
Main Results:
- Vaccinated monkeys showed reduced incidence and severity of dysentery compared to controls.
- High titers of protective antibodies were detected in the serum of immunized animals.
- Vaccination did not significantly alter the incidence, duration, or intermittent shedding of Shigella.
Conclusions:
- Oral polyvalent Shigella vaccination in rhesus monkeys elicits a humoral immune response.
- Despite antibody production, the vaccine did not provide complete protection against challenge or prevent bacterial shedding.
- Further research is needed to develop more effective Shigella vaccines targeting mucosal immunity and colonization.